Cambridge professor cautious about calling vaccines ‘safe and effective’
1 year, 1 month ago

Cambridge professor cautious about calling vaccines ‘safe and effective’

The Telegraph  

A Cambridge professor has said he is cautious about calling vaccines “safe and effective” because there will always be medical exceptions that need to be taken into account. Sir David Spiegelhalter, emeritus professor of statistics at the University of Cambridge, said a “very small proportion” of people have been harmed by the AstraZeneca vaccine, of which more than 50 million doses have been given in the UK. Sir David said he could not comment on Mr Scott’s “really unfortunate” situation but said that while people had been harmed by the vaccine, it was only a small proportion of the millions of people who received the jab. Speaking on BBC Radio 4’s Today programme, he said he had initially been sceptical about the blood clot risk from the AstraZeneca vaccine, but that it later became “quite clear and apparent” it was an issue, albeit very rare, that meant the harms “could very well outweigh the benefits” for young people.

Vaccine Cambridge Sir David  proportion  effective  vaccines  cambridge  rare  david  small  cautious  vaccine  taken  calling  blood  safe  professor

History of this topic

BORIS JOHNSON: Why I considered invading Holland with a dramatic canal raid to snatch our five million stolen vaccines back from Brussels' clutches
2 months, 3 weeks ago

BORIS JOHNSON: Why I considered invading Holland with a dramatic canal raid to snatch our five million stolen vaccines back from Brussels' clutches

Daily Mail  

Britain's top brass filed into my office in No 10, bearing with them hundreds of years of collective operational experience, from Afghanistan to Zimbabwe. Boris receives his Covid booster Jab at London's St Thomas' Hospital in December 2021 A nurse holds a phial of the Pfizer BioNTech Covid vaccine at Guy's Hospital in London as the immunisation programme begins in …

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case
1 year, 1 month ago

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case

The Telegraph  

As many as 80 claimants could lodge legal cases with the High Court by the end of the year in a class action that threatens to undermine faith in the rollout of the AstraZeneca vaccine that was developed jointly with Oxford University. In Mr Scott’s claim, his lawyers argue that he suffered “personal injuries and consequential losses arising out of …

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist
2 years, 10 months ago

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} An Oxford …

Coronavirus: Oxford study finds AstraZeneca and Pfizer vaccines both prevent asymptomatic cases
3 years, 8 months ago

Coronavirus: Oxford study finds AstraZeneca and Pfizer vaccines both prevent asymptomatic cases

Daily Mail  

Vaccines will allow us to control coronavirus without the need for future lockdowns, the experts behind a major new British study declared last night. The study found that there were significantly more coronavirus cases among people who hadn't been vaccinated than there were in people who had been given jabs or who had had Covid before The longer it had …

AstraZeneca: Europe’s vaccine rollout needs the shot – but public confidence is dented
3 years, 9 months ago

AstraZeneca: Europe’s vaccine rollout needs the shot – but public confidence is dented

CNN  

CNN — The European Union aims to vaccinate 70% of its adult population by September. Eliot Blondet/Abaca/Sipa USA Michael Head, senior research fellow in global health at the University of Southampton in the UK, said the decision to hit pause on Oxford-AstraZeneca could “have possibly a serious knock-on effect, in terms of vaccine confidence and vaccine hesitancy and uptake beyond …

Doctors fear Europe's Oxford-AstraZeneca vaccine bans have 'cost lives' and could have consequences for the world
3 years, 9 months ago

Doctors fear Europe's Oxford-AstraZeneca vaccine bans have 'cost lives' and could have consequences for the world

ABC  

The suspension of the Oxford-AstraZeneca vaccine rollout across much of Europe will likely be lifted soon. Key points: Four of the EU's largest nations suspended the use of the Oxford-AstraZeneca vaccine after reports of illnesses among some recipients Four of the EU's largest nations suspended the use of the Oxford-AstraZeneca vaccine after reports of illnesses among some recipients The pause …

Canada recommends AstraZeneca-Oxford vaccine for seniors
3 years, 9 months ago

Canada recommends AstraZeneca-Oxford vaccine for seniors

Al Jazeera  

Canadian officials and experts have sought to assure the vaccine is safe, even as several countries have paused its use. The vote of confidence comes as several, mostly European, countries have temporarily suspended the use of the AstraZeneca inoculant over fears it might have caused some recipients to develop blood clots, despite assurances from the British-Swedish multinational, the European Union …

Pfizer, AstraZeneca Covid vaccines highly effective in elderly, shows UK study
3 years, 9 months ago

Pfizer, AstraZeneca Covid vaccines highly effective in elderly, shows UK study

India Today  

The Pfizer and Oxford-AstraZeneca vaccines have been "highly effective" in reducing coronavirus infections and severe illness among elderly people in Britain, with a more than 80 per cent reduction in hospitalisation, official data showed Monday. In the over 80s, a single dose of either vaccine is more than 80 per cent effective at preventing hospitalisation around three to four weeks …

One jab of either Pfizer or Oxford-AstraZeneca offers 90% protection
3 years, 9 months ago

One jab of either Pfizer or Oxford-AstraZeneca offers 90% protection

India TV News  

Just one vaccine shot reduces the risk of being hospitalised by Covid-19 by more than 90 per cent, according to new findings, Daily Mail reported. Public health officials have told Ministers in the UK that the remarkable results apply for both the Pfizer and Oxford-AstraZeneca vaccine, with the British jab proving slightly more effective, the report said. A single shot …

WHO Backs Oxford Vaccine for All Above 18, Despite Variants
3 years, 10 months ago

WHO Backs Oxford Vaccine for All Above 18, Despite Variants

The Quint  

Andrew Pollard, Professor of Paediatric Infection and Immunity, and Chief Investigator on the Oxford vaccine trial, said in a quote on Oxford website, "The new guidance from WHO is an important milestone in extending access to the Oxford-AZ vaccine to all corners of the world and providing further endorsement that after rigorous scrutiny by the WHO Strategic Advisory Group of …

Oxford-AstraZeneca Vaccine Effective Against UK Covid-19 Variant, Study Finds
3 years, 10 months ago

Oxford-AstraZeneca Vaccine Effective Against UK Covid-19 Variant, Study Finds

News 18  

The COVID-19 vaccine developed by Oxford University and produced by AstraZeneca has shown efficacy against the UK variant of the coronavirus, according to an ongoing study by researchers. Oxford University scientists who developed the ChAdOx1-nCoV19 vaccine have found that it remains effective against at least one of the new variants of the disease, called the B.1.1.7 Kent' coronavirus strain after …

Oxford-AstraZeneca COVID-19 vaccine 'should be' effective against new UK strain: report
3 years, 11 months ago

Oxford-AstraZeneca COVID-19 vaccine 'should be' effective against new UK strain: report

Firstpost  

The only way to receive a jab in the UK is through the state-funded NHS, even though private clinics are receiving daily requests from patients attempting to jump the queue. The coronavirus vaccine developed by Oxford University and AstraZeneca “should be” effective against the highly transmissible new strain of the virus, a UK media report said on Sunday. “The latest …

Oxford/AstraZeneca COVID-19 vaccine should be effective against new variant: Report
3 years, 11 months ago

Oxford/AstraZeneca COVID-19 vaccine should be effective against new variant: Report

The Hindu  

The coronavirus vaccine developed by Oxford University and AstraZeneca “should be” effective against the highly transmissible new strain of the virus, a UK media report said on Sunday. AstraZeneca’s chief executive, Pascal Soriot, said that new data will show the vaccine is as effective as the Pfizer and Moderna jabs that have already been approved, protecting 95 per cent of …

Oxford's Covid vaccine will protect 95% of patients, as effective as Pfizer, Moderna: AstraZeneca CEO
3 years, 11 months ago

Oxford's Covid vaccine will protect 95% of patients, as effective as Pfizer, Moderna: AstraZeneca CEO

India Today  

Oxford University and AstraZeneca's coronavirus vaccine will protect "95 per cent of patients" who get it, Pascal Soriot said. With its vaccine reporting an efficacy rate of over 94 per cent, Pfizer is yet to publish the date pertaining to its late stage clinical trials. Pascal Soriot, CEO of AstraZeneca told British daily the Sunday Times that Oxford's Covid-19 vaccine …

Covid vaccine: Oxford-AstraZeneca jab is safe and up to 90% effective, new analysis confirms
4 years ago

Covid vaccine: Oxford-AstraZeneca jab is safe and up to 90% effective, new analysis confirms

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. So that work’s underway.” However, Dr Merryn Voysey, author of the report, said that further …

Covishield: Oxford's Covid vaccine has 70% efficacy, shows peer-reviewed result in Lancet
4 years ago

Covishield: Oxford's Covid vaccine has 70% efficacy, shows peer-reviewed result in Lancet

India Today  

Researchers at the University of Oxford who have been involved in the development of the varsity's Covid-19 vaccine candidate - Covishield - on Tuesday published the first peer-reviewed results of a Phase 3 trial of the vaccine candidate. Peer-reviewed analysis of Phase 3 trials of the Oxford vaccine tested across two different dose regimens has been published by leading medical …

AstraZeneca-Oxford Covid vaccine faces more questions after manufacturing error
4 years ago

AstraZeneca-Oxford Covid vaccine faces more questions after manufacturing error

Live Mint  

AstraZeneca Plc and the University of Oxford, among the front-runners in the quest to deliver a Covid-19 vaccine, face mounting questions about their trial results after acknowledging a manufacturing error. AstraZeneca and Oxford had said their vaccine was 90% effective when a half-dose was given before a full-dose booster, and that two full doses showed an efficacy of 62%. The …

AstraZeneca-Oxford University's COVID-19 vaccine shows average efficacy of 70%, says manufacturer
4 years, 1 month ago

AstraZeneca-Oxford University's COVID-19 vaccine shows average efficacy of 70%, says manufacturer

Firstpost  

Additionally, the drug manufacturer said that another regiment of a half dose, followed by a full dose at least one month apart was 90 percent effective London: AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90 percent effective in preventing disease. A half dose of the vaccine followed by a full …

What experts say on Oxford covid vaccine results
4 years, 1 month ago

What experts say on Oxford covid vaccine results

Live Mint  

AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, the latest drugmaker to unveil positive interim data in a scientific race to curb a global pandemic. Pascal Soriot, Chief Executive Officer, Astrazeneca "This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have …

AstraZeneca Says Covid-19 Vaccine Shows Average 70% Efficacy
4 years, 1 month ago

AstraZeneca Says Covid-19 Vaccine Shows Average 70% Efficacy

News 18  

British drugs group AstraZeneca and the University of Oxford on Monday said their jointly-developed vaccine against Covid-19 has shown “an average efficacy of 70 percent” in trials. “This vaccine’s efficacy and safety confirm that it will be highly effective against Covid-19 and will have an immediate impact on this public health emergency,” AstraZeneca chief executive Pascal Soriot said in a …

AstraZeneca Oxford vaccine is 70% effective on average, data shows
4 years, 1 month ago

AstraZeneca Oxford vaccine is 70% effective on average, data shows

CNN  

CNN — Drugmaker AstraZeneca announced on Monday that its experimental coronavirus vaccine has shown an average efficacy of 70% in large-scale trials – the latest of several vaccine trials worldwide to post their results this month. AstraZeneca has pledged to “ensure broad and equitable access to the vaccine at no profit for the duration of the pandemic.” Speaking on CNBC …

AstraZeneca COVID-19 vaccine can be 90% effective, results show
4 years, 1 month ago

AstraZeneca COVID-19 vaccine can be 90% effective, results show

Al Jazeera  

UK group is the latest drugmaker to unveil positive interim data in a scientific race to curb a global pandemic. “This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency,” AstraZeneca chief executive Pascal Soriot said in a statement on Monday. Monday’s statement said: “Positive …

Discover Related